A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Roivant Sciences Ltd’s current trading price is -4.02% away from its 52-week high, while its distance from the 52-week low is 45.51%. The stock’s price range for this time frame has been between $8.61 and $13.06. The trading volume of the company’s shares in the Healthcare reached around 11.36 million for the day, which was evidently higher than the average daily volume of 6.03 million over the last three months.
Roivant Sciences Ltd’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $13.06 on 09/09/24, and the lowest price during that time was $8.61, recorded on 11/27/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Roivant Sciences Ltd (ROIV) has experienced a quarterly rise of 6.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.67B and boasts a workforce of 908 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.52, with a change in price of +2.05. Similarly, Roivant Sciences Ltd recorded 5,577,345 in trading volume during the last 100 days, posting a change of +19.56%.
How ROIV’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ROIV stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
ROIV Stock Stochastic Average
The raw stochastic average for Roivant Sciences Ltd over the last 50 days is presently at 97.38%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 97.38%. Further, the company’s Stochastic %K and %D values for the last 20 days were 70.29% and 47.31%, respectively.
ROIV Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 11.58% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 14.12%. Over the past 30 days, the price of ROIV has fallen by 6.19%. And in the last five days, it has surged by 11.87%.
